Lyell Immunopharma, Inc.LYELNASDAQ
LOADING
|||
Switch Symbol:
Year-over-year net income growth rate
| Period | Value |
|---|---|
| Q3 2025 | 8.99% |
| Q2 2025 | 18.22% |
| Q1 2025 | 72.81% |
| Q4 2024 | -330.51% |
| Q3 2024 | 2.68% |
| Q2 2024 | 24.49% |
| Q1 2024 | -14.62% |
| Q4 2023 | -4.08% |
| Q3 2023 | 20.41% |
| Q2 2023 | 4.58% |
| Q1 2023 | -697.42% |
| Q4 2022 | 88.05% |
| Q3 2022 | -93.41% |
| Q2 2022 | 46.70% |
| Q1 2022 | 18.59% |
| Q4 2021 | -71.27% |
| Q3 2021 | 21.92% |
| Q2 2021 | -13.72% |
| Q1 2021 | -41.66% |
| Q4 2020 | -8.79% |
| Q3 2020 | 64.51% |
| Q2 2020 | -244.24% |
| Q1 2020 | 0.00% |